(Q33369978)

26 July 2017

Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: a double-blind placebo-controlled trial (English)

1 reference

26 July 2017

0 references

peripheral neuropathy

1 reference

2

Julio Rosenstock

1 reference

26 July 2017

Joseph C Arezzo

1

1 reference

26 July 2017

Linda Lamoreaux

series ordinal

3

1 reference

26 July 2017

Lynne Pauer

series ordinal

4

1 reference

26 July 2017

16 September 2008

1 reference

26 July 2017

1 reference

26 July 2017

8

1 reference

26 July 2017

33

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2377-8-33

26 July 2017

0 references

cites work

Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2565674

EFNS guidelines on pharmacological treatment of neuropathic pain.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2565674

Consensus guidelines: treatment planning and options. Diabetic peripheral neuropathic pain

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2565674

Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2565674

Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2565674

Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2565674

Diabetic neuropathies: a statement by the American Diabetes Association

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2565674

Pregabalin: in the treatment of painful diabetic peripheral neuropathy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2565674

Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2565674

Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2565674

Diabetic somatic neuropathies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2565674

Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2565674

Electrophysiologic measures of diabetic neuropathy: mechanism and meaning

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2565674

New developments in the diagnosis of diabetic neuropathy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2565674

Pathology and pathogenetic mechanisms of diabetic neuropathy.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2565674

Calculating confidence intervals for some non-parametric analyses

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2565674

Sleep impairment in patients with painful diabetic peripheral neuropathy

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-8-33

Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-8-33

Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-8-33

Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-8-33

Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-8-33

Monotonicity of nerve tests in diabetes: subclinical nerve dysfunction precedes diagnosis of polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-8-33

The short-form McGill Pain Questionnaire

21 January 2018

1 reference

12 December 2020

Meaningful degrees of prevention or improvement of nerve conduction in controlled clinical trials of diabetic neuropathy

1 reference

12 December 2020

Proceedings of a consensus development conference on standardized measures in diabetic neuropathy. Clinical measures

1 reference

12 December 2020

Electrophysiological monitoring in clinical trials. Roche Neuropathy Study Group

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2377-8-33

1 reference

Dimensions Publication ID

26 July 2017

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2377-8-33

9 September 2019

1 reference

26 July 2017

1 reference